首页> 外文期刊>Chemico-biological interactions >Alterations of the composition and metabolism of pulmonary surfactant phospholipids induced by experimental peritonitis in rats.
【24h】

Alterations of the composition and metabolism of pulmonary surfactant phospholipids induced by experimental peritonitis in rats.

机译:实验性腹膜炎引起的大鼠肺表面活性物质磷脂组成和代谢的变化。

获取原文
获取原文并翻译 | 示例
           

摘要

Pulmonary complications often accompany the development of acute peritonitis. In this study, we analyzed the alterations of alveolar surfactant phospholipids in rats with experimentally induced peritonitis. The results showed a reduction of almost all phospholipid fractions in pulmonary surfactant of experimental animals. The most abundant alveolar phospholipids-phosphatidylcholine and phosphatidylglycerol were reduced significantly in surfactant of rats with experimental peritonitis. In addition, analysis of the fatty acid composition of these two phospholipids revealed marked differences between experimental and control animals. The activity of phospholipase A2, which is localized in the hydrophyllic phase of alveolar surfactant, was higher in rats with experimental peritonitis compared to sham-operated ones. Also, a weak acyl-CoA:lysophospholipid acyltransferase activity was detected in alveolar surfactant of rats with experimental peritonitis, whereas in control animals this activity was not detectable. The lipid-transfer activity was quite similar in pulmonary surfactant of control and experimental rats. The total number of cells and the percentage of neutrophils were strongly increased in broncho-alveolar lavage fluid from rats with peritonitis. Thus, our results showed that the development of peritonitis was accompanied by pulmonary pathophysiological processes that involved alterations of the phospholipid and fatty acid composition of alveolar surfactant. We suggest that the increased populations of inflammatory cells, which basically participate in internalization and secretion of surfactant components, contributed to the observed alterations of alveolar phospholipids. These studies would be useful for clarification of the pathogenic mechanisms underlying the occurrence of pulmonary disorders that accompany acute inflammatory conditions, such as peritonitis and sepsis.
机译:肺部并发症通常伴随急性腹膜炎的发展。在这项研究中,我们分析了实验性腹膜炎大鼠肺泡表面活性剂磷脂的变化。结果表明,实验动物的肺表面活性剂中几乎所有磷脂组分均减少。实验性腹膜炎大鼠的表面活性剂中最丰富的肺泡磷脂-磷脂酰胆碱和磷脂酰甘油减少。另外,对这两种磷脂的脂肪酸组成的分析表明,实验动物和对照动物之间存在显着差异。与假手术组相比,实验性腹膜炎大鼠的磷脂酶A2活性位于肺泡表面活性剂的亲水相中。此外,在实验性腹膜炎大鼠的肺泡表面活性剂中检测到弱的酰基辅酶A:溶血磷脂酰基转移酶活性,而在对照动物中则未检测到该活性。对照组和实验组大鼠肺表面活性物质的脂质转移活性非常相似。腹膜炎大鼠支气管肺泡灌洗液中的细胞总数和中性粒细胞百分比均显着增加。因此,我们的结果表明腹膜炎的发展伴随着肺病理生理过程,涉及肺泡表面活性剂的磷脂和脂肪酸组成的改变。我们建议增加的炎症细胞数量,基本上参与表面活性剂成分的内在化和分泌,有助于观察到的肺泡磷脂改变。这些研究对于阐明伴随急性炎性疾病例如腹膜炎和败血症的肺部疾病的发生的致病机制将是有用的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号